NDC Code(s) : 76296-013-40
Packager : Caudalie USA Inc.

Category : HUMAN PRESCRIPTION DRUG LABEL

DEA Schedule : none

Marketing Status : New Drug Application

INGREDIENTS AND APPEARANCE

Vinoperfect Radiance Moisturizer Broad Spectrum SPF20Avobenzone, Octinoxate, Octisalate, Octocrylene CREAM
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:76296-013
Route of Administration TOPICAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
AVOBENZONE(UNII: G63QQF2NOX)
(AVOBENZONE - UNII:G63QQF2NOX) 		AVOBENZONE30 mg in 1 mL
OCTINOXATE(UNII: 4Y5P7MUD51)
(OCTINOXATE - UNII:4Y5P7MUD51) 		OCTINOXATE39.96 mg in 1 mL
OCTISALATE(UNII: 4X49Y0596W)
(OCTISALATE - UNII:4X49Y0596W) 		OCTISALATE50 mg in 1 mL
OCTOCRYLENE(UNII: 5A68WGF6WM)
(OCTOCRYLENE - UNII:5A68WGF6WM) 		OCTOCRYLENE80 mg in 1 mL
Inactive Ingredients
Ingredient Name Strength
HEPTYL UNDECYLENATE(UNII: W77QUB6GXO)
DIMETHICONE(UNII: 92RU3N3Y1O)
ISOAMYL LAURATE(UNII: M1SLX00M3M)
SQUALANE(UNII: GW89575KF9)
GLYCERYL STEARATE CITRATE(UNII: WH8T92A065)
GLYCERIN(UNII: PDC6A3C0OX)
SILICON DIOXIDE(UNII: ETJ7Z6XBU4)
TITANIUM DIOXIDE(UNII: 15FIX9V2JP)
BUTYLENE GLYCOL(UNII: 3XUS85K0RA)
MICA(UNII: V8A1AW0880)
.ALPHA.-TOCOPHEROL ACETATE(UNII: 9E8X80D2L0)
LEVOMENOL(UNII: 24WE03BX2T)
BENZYL ALCOHOL(UNII: LKG8494WBH)
CAPRYLYL GLYCOL(UNII: 00YIU5438U)
ALUMINUM OXIDE(UNII: LMI26O6933)
ANNICKIA CHLORANTHA BARK(UNII: H70115MP4A)
DEHYDROACETIC ACID(UNII: 2KAG279R6R)
HYALURONIC ACID(UNII: S270N0TRQY)
PAPAIN(UNII: A236A06Y32)
1,2-HEXANEDIOL(UNII: TR046Y3K1G)
BUTYLATED HYDROXYTOLUENE(UNII: 1P9D0Z171K)
SODIUM ALGINATE(UNII: C269C4G2ZQ)
TOCOPHEROL(UNII: R0ZB2556P8)
OLEANOLIC ACID(UNII: 6SMK8R7TGJ)
GERANIOL(UNII: L837108USY)
LINALOOL, (+/-)-(UNII: D81QY6I88E)
Packaging
# Item Code Package Description Marketing Start Date Marketing End Date
1NDC:76296-013-401 in 1 BOX 02/04/2015
140 mL in 1 TUBE Type 0: Not a Combination Product
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
OTC monograph not final part352 04/02/2015 02/28/2018

PRINCIPAL DISPLAY PANEL

DrugFactsDrugFacts